Search results
After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals,...
Zacks via Yahoo Finance· 1 year agoThe heavy selling pressure might have exhausted for Citius Pharmaceuticals, Inc. (CTXR) as it is...
Citius Pharma To Spinoff Late-Stage Oncology Asset Into New Publicly Traded Firm
Benzinga via Yahoo Finance· 2 years agoCitius Pharmaceuticals Inc (NASDAQ: CTXR) plans to form a new company (NewCo) focused on developing...
Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Shift From Loss To Profit
Simply Wall St. via Yahoo Finance· 2 years agoCitius Pharmaceuticals, Inc. (NASDAQ:CTXR) is possibly approaching a major achievement in its...
3 Reddit Stocks to Buy in May
InvestorPlace via Yahoo Finance· 2 years agoThese trending Reddit stocks have considerable growth catalysts in motion, offering healthy upside potential in May and beyond. AdvisorShares Pure U.S....
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings
Benzinga via Yahoo Finance· 2 years agoCitius Pharmaceuticals Inc (NASDAQ: CTXR) collaborated with the University of Pittsburgh for I/ONTAK...
Here's Why Citius Pharmaceuticals (NASDAQ:CTXR) Must Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
We Think Citius Pharmaceuticals (NASDAQ:CTXR) Needs To Drive Business Growth Carefully
Simply Wall St. via Yahoo Finance· 5 months agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Combination Therapy for Hemorrhoids: Citius' Combination Products Shows Meaningful Reduction In...
Benzinga via Yahoo Finance· 10 months agoCitius Pharmaceuticals Inc's (NASDAQ: CTXR) Halo-Lido, a topical treatment comprising lidocaine and...
Citius Pharmaceuticals Inc (CTXR) Reports Q1 2024 Financials and Progress in Clinical Trials
GuruFocus.com via Yahoo Finance· 2 months agoLiquidity: Citius Pharmaceuticals Inc (NASDAQ:CTXR) reported $20.3 million in cash and cash equivalents as of December 31, 2023. Shares Outstanding: As of December 31, 2023, there were 158,966,576 ...
